✦ LIBER ✦

What we have learned from the xaliproden Sanofi-aventis trials

✍ Scribed by P. Douillet; J. -M. Orgogozo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

What we have learned from the myriad tri

✍ S. B. Hendrix; G. K. Wilcock 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 397 KB

What have we learned from recent dyspeps

✍ Joshua J. Ofman 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 366 KB

What Have We Learned from the Case Studi

✍ Donald M. Norris; James L. Morrison 📂 Article 📅 1997 🏛 John Wiley and Sons ⚖ 63 KB

Prostate Cancer Screening: What We Have

✍ Jeffrey La Rochelle; Christopher L. Amling 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 93 KB

What Have We Learned from the Congenital

✍ Andrew G. Engel; Xin-Ming Shen; Duygu Selcen; Steven M. Sine 📂 Article 📅 2009 🏛 Humana Press Inc 🌐 English ⚖ 772 KB

Supercomputing: What have we learned fro

✍ Erich Strohmaier; Hans W. Meuer 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 224 KB